Federal initiatives focused on lowering drug costs, access to care, patient data, and more are all affecting the future of specialty pharmacies. There is also specific legislation at the state level regarding such issues as scope of practice and reimbursement. This session will shine a spotlight on some of the regulatory and policy changes that are currently shifting the specialty pharmacy landscape, with impacts on patients and industry stakeholders alike.